‘Abuse Deterrent’ ADHD Tx May Face Uphill Approval Path
An abuse-deterrent stimulant product for attention deficit-hyperactivity disorder (ADHD) got a skeptical review from FDA technical staff ahead of an advisory committee meeting later this week.
Other Articles in this Edition
Navigating Complex ADHD in Children and Teens In Uncertain Times
Study: People with ADHD more likely to recover from COVID
‘Abuse Deterrent’ ADHD Tx May Face Uphill Approval Path
Strategies for Treating Patients With Both ADHD and SUD
The Importance of Using Multiple Approaches When Treating Pediatric ADHD
ADHD increases odds of diabetes independent of BMI
Prenatal Acetaminophen Exposure Associated with Increased ADHD Risk
School changes – helping children with ADHD
Everything I want to tell my adult ADHD patients during the pandemic